LAVIPHARM

Agias Marinas Street

PO Box 59

GR-19002 Peania Attica, Greece

Tel.: +30 210 6691 000, Fax: +30 210 6642 310

For more information or suggestions, please contact the following departments:

Human Resources Department:

Tel: (30) 210 6691 151

Fax: (30) 210 6691 159

E-Mail: hr@lavipharm.com

Corporate Communications Department:

Katerina Fragioudakis

Executive Assistant to the Chairman

Head of Corporate Communications

Tel: (30) 210 6691 106

Fax: (30) 210 6691 208

E-Mail: communications@lavipharm.com

Investor Relations:

Liana Dimitrakopoulou

Investor Relations Officer

Tel: (30) 210 6691 141

Fax: (30) 210 6691 129

E-Mail: ir@lavipharm.com


Pharmacovigilance:

Tel.: (30) 210 6691 396, (30) 210 6691 166

Fax: (30) 210 6691 169

E-mail: SafetyGreece@lavipharm.com


International Business Operating Unit

Tel: (30) 210 6691 310

Fax: (30) 210 6691 309

E-Mail: international@lavipharm.com


Business Development:

Dr. Katerina Tsardaka

Business Development Director

Tel.: (30) 210 6691 312

Fax: (30) 210 6691 309

E-Mail: businessdevelopment@lavipharm.com


LABORATOIRES LAVIPHARM

27 Rue de Marignan

F-75008 Paris, France

Tel.: +33 1 5364 6400

Fax: +33 1 5364 6419

HITEX

ZI Pentaparc

BP 33601

56036 - Vannes Cedex

FRANCE

Tel.: +33 (0)2 97 68 88 88

Fax: +33 (0)2 97 68 88 80

www.hitex-co2.com


LAVIPHARM Corp.

69 Princeton – Hightstown Road

East Windsor,

NJ 08520, U.S.A.

Tel.: +1 609 448 3001

Fax: +1 609 371 6502